Active, not recruitingNo phase
Screening for Abdominal Aortic Aneurysm and Popliteal Artery Aneurysm
Key facts
- Who runs it
- Centre Hospitalier Universitaire Vaudois
- Where
- Italy and Switzerland5 sites in 2 countriesChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 507 people enrolled
- Started
- 1 Jun 2020
- Expected to end
- 30 Jun 2029
- Type of study
- Observational
- Record updated
- 16 March 2026
Who can take part
- Age
- 55 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Women aged ≥65 years who are current smokers
- Men aged ≥65 years
- Women or Men aged ≥55 years with family history (first-degree relatives) for Abdominal Aortic Aneurysm (AAA) or popliteal artery aneurysm (PAA)
Who cannot take part
- Patient with known diagnosis of AAA or PAA
- Patient already operated for AAA or PAA
- AAA/PAA screening or arterial assessment of lower limbs within the last 12 months
- Inability to understand and/or sign study consent
- Inability to access follow-up controls
This trial has no sites in United States.
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
Observational, prospective, cohort study to evaluate, by an opportunistic screening program based on vascular ultrasound, the prevalence and characteristics of Abdominal Aortic Aneurysm (AAA) and Popliteal Artery Aneurysm (PAA) in a female population as well as the prevalence and characteristics of PAA in male population.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Screening for Abdominal Aortic Aneurysm and Popliteal Artery Aneurysm in At-risk Population (DAAP-PR Study)
- Record updated
- 16 March 2026